{
    "xml": "<topic id=\"PHP944\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/propranolol-hydrochloride\" basename=\"propranolol-hydrochloride\" title=\"PROPRANOLOL HYDROCHLORIDE\">\n<title>PROPRANOLOL HYDROCHLORIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_793\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/propranolol\">Propranolol</xref>\n</p>\n<data name=\"vtmid\">55745002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_613648210\" title=\"Beta-adrenoceptor blockers\">Beta-adrenoceptor blockers</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP60846\" outputclass=\"indicationsAndDose\" rev=\"1.33\" parent=\"/drugs/propranolol-hydrochloride\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Thyrotoxicosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;40&#8239;mg 3&#8211;4 times a day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Thyrotoxic crisis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum total dose is 5&#8239;mg in anaesthesia; maximum 10&#8239;mg per course.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypertension</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 80&#8239;mg twice daily, dose should be increased at weekly intervals as required; maintenance 160&#8211;320&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of variceal bleeding in portal hypertension</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8239;mg twice daily, then increased to 80&#8239;mg twice daily (max. per dose 160&#8239;mg twice daily), dose to be adjusted according to heart rate.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Phaeochromocytoma (only with an alpha-blocker) in preparation for surgery</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>60&#8239;mg daily for 3 days before surgery.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Phaeochromocytoma (only with an alpha-blocker) in patients unsuitable for surgery</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>30&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Angina</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8239;mg 2&#8211;3 times a day; maintenance 120&#8211;240&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypertrophic cardiomyopathy</p>\n<p outputclass=\"therapeuticIndication\">Anxiety tachycardia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;40&#8239;mg 3&#8211;4 times a day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Anxiety with symptoms such as palpitation, sweating and tremor</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg once daily, then increased if necessary to 40&#8239;mg 3 times a day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis after myocardial infarction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8239;mg 4 times a day for 2&#8211;3 days, then 80&#8239;mg twice daily, start treatment 5 to 21 days after infarction.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Essential tremor</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8239;mg 2&#8211;3 times a day; maintenance 80&#8211;160&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Migraine prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>80&#8211;240&#8239;mg daily in divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Arrhythmias</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum total dose is 5&#8239;mg in anaesthesia; maximum 10&#8239;mg per course.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60819\" outputclass=\"sideEffects\" rev=\"1.31\" parent=\"/drugs/propranolol-hydrochloride\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dry eyes (reversible on withdrawal)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60973\" outputclass=\"hepaticImpairment\" parent=\"/drugs/propranolol-hydrochloride\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce oral dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60830\" outputclass=\"renalImpairment\" parent=\"/drugs/propranolol-hydrochloride\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Manufacturer advises caution; dose reduction may be required.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62280\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.15\" parent=\"/drugs/propranolol-hydrochloride\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Modified-release preparations can be used for once daily administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP944-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/propranolol-hydrochloride\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74871\" title=\"Tablet\" namespace=\"/drugs/propranolol-hydrochloride/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74866\" title=\"Modified-release capsule\" namespace=\"/drugs/propranolol-hydrochloride/modified-release-capsule\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74894\" title=\"Oral solution\" namespace=\"/drugs/propranolol-hydrochloride/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78144\" namespace=\"/treatment-summaries/acute-coronary-syndromes\" title=\"Acute coronary syndromes\" count=\"1\" rel=\"backlink\">Acute coronary syndromes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78218\" namespace=\"/treatment-summaries/beta-adrenoceptor-blocking-drugs\" title=\"Beta-adrenoceptor blocking drugs\" count=\"2\" rel=\"backlink\">Beta-adrenoceptor blocking drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78238\" namespace=\"/treatment-summaries/migraine\" title=\"Migraine\" count=\"2\" rel=\"backlink\">Migraine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78280\" namespace=\"/treatment-summaries/antithyroid-drugs\" title=\"Antithyroid drugs\" count=\"4\" rel=\"backlink\">Antithyroid drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78291\" namespace=\"/treatment-summaries/arrhythmias\" title=\"Arrhythmias\" count=\"1\" rel=\"backlink\">Arrhythmias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78531\" namespace=\"/treatment-summaries/parkinsons-disease-and-related-disorders\" title=\"Parkinson&#8217;s disease and related disorders\" count=\"1\" rel=\"backlink\">Parkinson&#8217;s disease and related disorders</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_793\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/propranolol\" title=\"Propranolol\" count=\"1\" rel=\"link\">Propranolol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" count=\"1\" rel=\"link\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74871\" namespace=\"/drugs/propranolol-hydrochloride/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74866\" namespace=\"/drugs/propranolol-hydrochloride/modified-release-capsule\" title=\"Modified-release capsule\" count=\"1\" rel=\"link\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74894\" namespace=\"/drugs/propranolol-hydrochloride/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP944",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/propranolol-hydrochloride",
    "basename": "propranolol-hydrochloride",
    "title": "PROPRANOLOL HYDROCHLORIDE",
    "interactants": [
        {
            "id": "bnf_int_793",
            "label": "Propranolol"
        }
    ],
    "vtmid": "55745002",
    "drugClassification": [
        "Beta-adrenoceptor blockers"
    ],
    "inheritsFromClass": [
        "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Thyrotoxicosis",
                        "html": "Thyrotoxicosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;40 mg 3&#8211;4 times a day.",
                        "html": "<p>10&#8211;40&#8239;mg 3&#8211;4 times a day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Thyrotoxic crisis",
                        "html": "Thyrotoxic crisis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "1 mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum total dose is 5 mg in anaesthesia; maximum 10 mg per course.",
                        "html": "<p>1&#8239;mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum total dose is 5&#8239;mg in anaesthesia; maximum 10&#8239;mg per course.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Hypertension",
                        "html": "Hypertension"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 80 mg twice daily, dose should be increased at weekly intervals as required; maintenance 160&#8211;320 mg daily.",
                        "html": "<p>Initially 80&#8239;mg twice daily, dose should be increased at weekly intervals as required; maintenance 160&#8211;320&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of variceal bleeding in portal hypertension",
                        "html": "Prophylaxis of variceal bleeding in portal hypertension"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40 mg twice daily, then increased to 80 mg twice daily (max. per dose 160 mg twice daily), dose to be adjusted according to heart rate.",
                        "html": "<p>Initially 40&#8239;mg twice daily, then increased to 80&#8239;mg twice daily (max. per dose 160&#8239;mg twice daily), dose to be adjusted according to heart rate.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Phaeochromocytoma (only with an alpha-blocker) in preparation for surgery",
                        "html": "Phaeochromocytoma (only with an alpha-blocker) in preparation for surgery"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "60 mg daily for 3 days before surgery.",
                        "html": "<p>60&#8239;mg daily for 3 days before surgery.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Phaeochromocytoma (only with an alpha-blocker) in patients unsuitable for surgery",
                        "html": "Phaeochromocytoma (only with an alpha-blocker) in patients unsuitable for surgery"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "30 mg daily.",
                        "html": "<p>30&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Angina",
                        "html": "Angina"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40 mg 2&#8211;3 times a day; maintenance 120&#8211;240 mg daily.",
                        "html": "<p>Initially 40&#8239;mg 2&#8211;3 times a day; maintenance 120&#8211;240&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Hypertrophic cardiomyopathy",
                        "html": "Hypertrophic cardiomyopathy"
                    },
                    {
                        "textContent": "Anxiety tachycardia",
                        "html": "Anxiety tachycardia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;40 mg 3&#8211;4 times a day.",
                        "html": "<p>10&#8211;40&#8239;mg 3&#8211;4 times a day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Anxiety with symptoms such as palpitation, sweating and tremor",
                        "html": "Anxiety with symptoms such as palpitation, sweating and tremor"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "40 mg once daily, then increased if necessary to 40 mg 3 times a day.",
                        "html": "<p>40&#8239;mg once daily, then increased if necessary to 40&#8239;mg 3 times a day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis after myocardial infarction",
                        "html": "Prophylaxis after myocardial infarction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40 mg 4 times a day for 2&#8211;3 days, then 80 mg twice daily, start treatment 5 to 21 days after infarction.",
                        "html": "<p>Initially 40&#8239;mg 4 times a day for 2&#8211;3 days, then 80&#8239;mg twice daily, start treatment 5 to 21 days after infarction.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Essential tremor",
                        "html": "Essential tremor"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40 mg 2&#8211;3 times a day; maintenance 80&#8211;160 mg daily.",
                        "html": "<p>Initially 40&#8239;mg 2&#8211;3 times a day; maintenance 80&#8211;160&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Migraine prophylaxis",
                        "html": "Migraine prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "80&#8211;240 mg daily in divided doses.",
                        "html": "<p>80&#8211;240&#8239;mg daily in divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Arrhythmias",
                        "html": "Arrhythmias"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "1 mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum total dose is 5 mg in anaesthesia; maximum 10 mg per course.",
                        "html": "<p>1&#8239;mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum total dose is 5&#8239;mg in anaesthesia; maximum 10&#8239;mg per course.</p>"
                    }
                ]
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Dry eyes (reversible on withdrawal)",
                        "html": "Dry eyes (reversible on withdrawal)",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce oral dose.",
                "html": "<p>Reduce oral dose.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Manufacturer advises caution; dose reduction may be required.",
                "html": "<p>Manufacturer advises caution; dose reduction may be required.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Modified-release preparations can be used for once daily administration.",
                "html": "<p>Modified-release preparations can be used for once daily administration.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74871",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74866",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74894",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78144",
                "label": "Acute coronary syndromes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78218",
                "label": "Beta-adrenoceptor blocking drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78238",
                "label": "Migraine",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78280",
                "label": "Antithyroid drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78291",
                "label": "Arrhythmias",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78531",
                "label": "Parkinson&#8217;s disease and related disorders",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_793",
                "label": "Propranolol",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34515",
                "label": "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74871",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74866",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74894",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}